Celaid Therapeutics Completes Second Close of Series B Financing Round
Shionogi President and CEO: Nobuyuki Arakawa; "Celaid") today announced the completion of the second close of its Series B financing round. The round welcomed Shionogi & Co., Ltd. and Teikoku









